Latest News
Featured News
Scancell announces CFO Transition
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
Select the category
Interim Results for the six months ended 31 October 2024
Notice of Interim Results
Scancell’s Modi-1 Moditope Vaccine Achieves Early Clinical Validation in Head and Neck Cancer
Scancell announces Genmab exercises option to a second commercial license agreement
Scancell announces further positive data from the ongoing SCOPE trial of SCIB1 with double CPIs for Advanced Melanoma
Result of 2024 Annual General Meeting
No results found.
Regulatory News Archive
JOIN OUR MAILING LIST
Sign up for news updates to stay up to date with Scancell.